bms-955176
Showing 1 - 9 of 9
Infection, Human Immunodeficiency Virus, HIV Trial in Berlin (BMS-955176, Placebo matching with BMS-955176, Atazanavir)
Completed
- Infection, Human Immunodeficiency Virus
- HIV Infections
- BMS-955176
- +5 more
-
Berlin, GermanyGSK Investigational Site
Nov 4, 2019
HIV Trial in Austin (CYP and transporter probe substrates, BMS-955176, BMS-955176 plus CYP and transporter probe substrates)
Completed
- HIV Infections
- CYP and transporter probe substrates
- +2 more
-
Austin, TexasGSK Investigational Site
Jul 11, 2018
HIV Trial in Madison (BMS-955176)
Completed
- HIV Infections
- BMS-955176
-
Madison, WisconsinGSK Investigational Site
Apr 13, 2018
Infection, Human Immunodeficiency Virus Trial (BMS-955176, Ortho Cyclen)
Completed
- Infection, Human Immunodeficiency Virus
- BMS-955176
- Ortho Cyclen
- (no location specified)
Apr 13, 2018
HIV Trial in Woburn (BMS-955176)
Completed
- HIV Infections
- BMS-955176
-
Woburn, MassachusettsGSK Investigational Site
Apr 13, 2018
Infection, Human Immunodeficiency Virus Trial in Worldwide (BMS-955176, EFV, TDF/FTC)
Terminated
- Infection, Human Immunodeficiency Virus
- BMS-955176
- +2 more
-
Beverly Hills, California
- +63 more
Aug 20, 2018
HIV Trial in Worldwide (BMS-955176, Atazanavir (ATV), Ritonavir (RTV))
Terminated
- HIV Infections
- BMS-955176
- +4 more
-
Beverly Hills, California
- +63 more
Aug 17, 2018
Infection, Human Immunodeficiency Virus Trial in Nottingham (BMS-955176)
Completed
- Infection, Human Immunodeficiency Virus
- BMS-955176
-
Nottingham, United KingdomGSK Investigational Site
Sep 7, 2017
Infection, Human Immunodeficiency Virus Trial in Ruddington Fields (BMS-955176)
Completed
- Infection, Human Immunodeficiency Virus
- BMS-955176
-
Ruddington Fields, Nottinghamshire, United KingdomGSK Investigational Site
Apr 13, 2017